To order chemicals, medical devices, or other restricted products please provide ID that includes your business name & shipping address via email [email protected] or fax 484.881.5997 referencing your VWR account number. Acceptable forms of ID are:
- • State issued document with your organization's Federal Tax ID Number
- • State issued document with your organization's Resale Tax ID Number
- • City or County issued Business License
- • State Department of Health Services License
- • Any other ID issued by the State that includes the business name & address
* ATTN: California Customers may require additional documentation as part of the CA Health & Safety Code. Products that fall under this regulation will be placed on a mandatory 21-day hold after documentation is received. Avantor will not lift restrictions for residential shipping addresses.
Specifications
- Description:Alkaline Phosphatase Assay Kit
- Size:250 assays
- Environmentally Preferable:
- Method:OD405 nm
- Sample:Serum, plasma, etc.
- Processing Time:Four minutes
- Cat. No.:75877-954
- Supplier no.:DALP-250
Specifications
About this item
For quantitative colorimetric determination of alkaline phosphatase (ALP) activity.
- Use only 5 μL serum or plasma sample. Linear detection range 2 - 800 U/L
- Simple "mix-and-measure"
- Procedure allows reliable quantitation of ALP activity within five minutes
- All reagents are compatible with high-throughput liquid handling instruments
Alkaline phosphatase (ALP) catalyzes the hydrolysis of phosphate esters in an alkaline environment, resulting in the formation of an organic radical and inorganic phosphate
BioAssay Systems’ QuantiChrom™ Alkaline Phosphatase Assay Kit is designed to measure ALP activity directly in biological samples without pretreatment. The improved method utilizes p-nitrophenyl phosphate that is hydrolyzed by ALP into a yellow colored product (maximal absorbance at 405nm). The rate of the reaction is directly proportional to the enzyme activity.
In mammals, this enzyme is found mainly in the liver and bones. Marked increase in serum ALP levels, a disease known as hyperalkalinephosphatasemia, has been associated with malignant biliary obstruction, primary biliary cirrhosis, primary sclerosing cholangitis, hepatic lymphoma and sarcoidosis. Simple, direct and automation-ready. Procedures for measuring ALP activity in serum are becoming popular in Research and Drug Discovery.